Training activity information
Details
Select, perform and interpret diagnostic techniques for the investigation of acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS)
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Morphological features associated with AML and MDS
- The sample type required and the preanalytical variables affecting results.
- Clinical presentations and other investigations
- National and international guidelines
- WHO classification
- Local SOPs
- Quality assurance
- Prioritisation and communication of results
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 3 |
Outcome
Perform a range of laboratory and molecular testing techniques to diagnose and monitor treatment of haematological malignancy in the correct clinical context, including the interpretation and reporting of results. |
| # 4 |
Outcome
Interpret and comply with national and international guidelines on the diagnosis and management of haematological cancer. |
| # 7 |
Outcome
Perform quality assurance and control tasks across the range of investigations. |